HopeStage
Back to all studies
CompletedNCT02697045

Long-Acting Aripiprazole and Daily Functioning in Schizophrenia

About this titleRead the official source — NCT02697045
Medication studyAges 18–45Türkiye
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 45 years.

Listed locations
Adana and 14 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 4, 2017
Recruitment status
Completed
Enrollment listed in the registry
23
Sponsor
Abdi İbrahim Otsuka
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Türkiye
Age range
From 18 Years to 45 Years
Official registry ID
NCT02697045
Official title
Show the full official title

Nautralsitic, Open-label, Single Arm Study Evaluating Effects of Aripiprazole LAI on Phychosocial&Congitive Functioning, Patient Reported Acceptability of Treatment Regarding QoL, Subjective Well-being Under Neuroleptic Medication in Sch

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Adana, Türkiye · Ankara, Türkiye · Bursa, Türkiye

8 more locations
  • Istanbul, Türkiye
  • Izmir, Türkiye
  • Kocaeli, Türkiye
  • Konya, Türkiye
  • Manisa, Türkiye
  • Mersin, Türkiye
  • Samsun, Türkiye
  • Türkiye

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Abdi İbrahim Otsuka.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole 400mg LAI.

Who was this study for?

Listed age limits: 18 years to 45 years.

Want to explore more studies?

Explore studies